138964-51-9 Usage
Uses
Used in Pharmaceutical Industry:
2,4(1H,3H)-Quinolinedione, 6-bromois used as a key intermediate in the development of drugs for various therapeutic applications, particularly in the creation of antimalarial and antitumor agents. Its unique structure and properties contribute to the effectiveness of these medications.
Used in Organic Light-Emitting Diodes (OLEDs):
6-bromo-2,4(1H,3H)-Quinolinedione is utilized in the research and development of organic light-emitting diodes due to its intriguing optical and electronic properties. Its potential in this field is being explored for enhancing the performance and efficiency of OLEDs.
Used in Optoelectronic Applications:
Beyond OLEDs, 2,4(1H,3H)-Quinolinedione, 6-bromois also considered for other optoelectronic applications, where its electronic properties can be leveraged to improve the performance of various devices and systems.
Check Digit Verification of cas no
The CAS Registry Mumber 138964-51-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,9,6 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 138964-51:
(8*1)+(7*3)+(6*8)+(5*9)+(4*6)+(3*4)+(2*5)+(1*1)=169
169 % 10 = 9
So 138964-51-9 is a valid CAS Registry Number.
138964-51-9Relevant academic research and scientific papers
Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors
Haffner, Curt D.,Becherer, J. David,Boros, Eric E.,Cadilla, Rodolfo,Carpenter, Tiffany,Cowan, David,Deaton, David N.,Guo, Yu,Harrington, Wallace,Henke, Brad R.,Jeune, Michael R.,Kaldor, Istvan,Milliken, Naphtali,Petrov, Kim G.,Preugschat, Frank,Schulte, Christie,Shearer, Barry G.,Shearer, Todd,Smalley, Terrence L.,Stewart, Eugene L.,Stuart, J. Darren,Ulrich, John C.
supporting information, p. 3548 - 3571 (2015/05/05)
A series of thiazoloquin(az)olinones were synthesized and found to have potent inhibitory activity against CD38. Several of these compounds were also shown to have good pharmacokinetic properties and demonstrated the ability to elevate NAD levels in plasm
